Home
>
National Drug Code (NDC)
>
Vivotif-B
Vivotif-B - 21695-526-04 - (Vivotif-B)
Drug Information of Vivotif-B
| Product NDC: | 21695-526 |
| Proprietary Name: | Vivotif-B |
| Non Proprietary Name: | Vivotif-B |
| Active Ingredient(s): | 2 [CFU]/1 & nbsp; Vivotif-B |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Vivotif-B
| Product NDC: | 21695-526 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103123 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19891215 |
Package Information of Vivotif-B
| Package NDC: | 21695-526-04 |
| Package Description: | 4 CAPSULE in 1 BLISTER PACK (21695-526-04) |
NDC Information of Vivotif-B
| NDC Code | 21695-526-04 |
| Proprietary Name | Vivotif-B |
| Package Description | 4 CAPSULE in 1 BLISTER PACK (21695-526-04) |
| Product NDC | 21695-526 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Vivotif-B |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19891215 |
| Marketing Category Name | BLA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI |
| Strength Number | 2 |
| Strength Unit | [CFU]/1 |
| Pharmaceutical Classes |
